Haemonetics (HAE) Tops Q2 EPS by 7c, Beats on Revenues
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $106.38 +17.85%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.48, $0.07 better than the analyst estimate of $0.41. Revenue for the quarter came in at $225 million versus the consensus estimate of $219.26 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
